首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >Co-existence of COPD and bronchiectasis: a risk factor for a high ratio of main pulmonary artery to aorta diameter (PA:A) from computed tomography in COPD patients
【24h】

Co-existence of COPD and bronchiectasis: a risk factor for a high ratio of main pulmonary artery to aorta diameter (PA:A) from computed tomography in COPD patients

机译:COPD和支气管扩张的并存:COPD患者通过计算机断层摄影术得出的主要肺动脉与主动脉直径(PA:A)高比的危险因素

获取原文
       

摘要

Background: Pulmonary vascular disease, especially pulmonary hypertension, is an important complication of COPD. Bronchiectasis is considered not only a comorbidity of COPD, but also a risk factor for vascular diseases. The main pulmonary artery to aorta diameter ratio (PA:A ratio) has been found to be a reliable indicator of pulmonary vascular disease. It is hypothesized that the co-existence of COPD and bronchiectasis may be associated with relative pulmonary artery enlargement (PA:A ratio >1). Methods: This retrospective study enrolled COPD patients from 2012 through 2016. Demographic and clinical data were collected. Bhalla score was used to determine the severity of bronchiectasis. Patient characteristics were analyzed in two ways: the high (PA:A >1) and low (PA:A ≤1) ratio groups; and COPD with and without bronchiectasis groups. Logistic regression analysis was used to assess risk factors for high PA:A ratios. Results: In this study, 480 COPD patients were included, of whom 168 had radiographic bronchiectasis. Patients with pulmonary artery enlargement presented with poorer nutrition (albumin, 35.6±5.1 vs 38.3±4.9, P <0.001), lower oxygen partial pressure (74.4±34.5 vs 81.3±25.4, P <0.001), more severe airflow obstruction (FEV1.0, 0.9±0.5 vs 1.1±0.6, P =0.004), and a higher frequency of bronchiectasis (60% vs 28.8%, P <0.001) than patients in the low ratio group. Patients with both COPD and bronchiectasis had higher levels of systemic inflammation (erythrocyte sedimentation rate, P <0.001 and fibrinogen, P =0.006) and PA:A ratios ( P <0.001). A higher PA:A ratio was significantly closely correlated with a higher Bhalla score (r=0.412, P <0.001). Patients with both COPD and bronchiectasis with high ratios presented higher levels of NT-proBNP ( P <0.001) and systolic pulmonary artery pressure ( P <0.001). Multiple logistic analyses have indicated that bronchiectasis is an independent risk factor for high PA:A ratios in COPD patients (OR =3.707; 95% CI =1.888–7.278; P <0.001). Conclusion: Bronchiectasis in COPD has been demonstrated to be independently associated with relative pulmonary artery enlargement.
机译:背景:肺血管疾病,尤其是肺动脉高压,是COPD的重要并发症。支气管扩张不仅被认为是COPD的合并症,也是血管疾病的危险因素。已发现主肺动脉与主动脉直径之比(PA:A之比)是肺血管疾病的可靠指标。假设COPD和支气管扩张并存可能与肺动脉相对扩张有关(PA:A比> 1)。方法:这项回顾性研究招募了2012年至2016年的COPD患者。收集了人口统计学和临床​​数据。 Bhalla评分用于确定支气管扩张的严重程度。用两种方法分析患者特征:高比率(PA:A> 1)和低比率(PA:A≤1);和有或没有支气管扩张组的COPD。 Logistic回归分析用于评估高PA:A比值的危险因素。结果:本研究共纳入480例COPD患者,其中168例患有影像学支气管扩张。肺动脉增大的患者营养不良(白蛋白35.6±5.1 vs 38.3±4.9,P <0.001),氧分压较低(74.4±34.5 vs 81.3±25.4,P <0.001),气流阻塞更严重(FEV1)。 0、0.9±0.5和1.1±0.6,P = 0.004)和比低比率组患者更高的支气管扩张发生率(60%比28.8%,P <0.001)。患有COPD和支气管扩张的患者的全身炎症水平较高(红细胞沉降率,P <0.001和纤维蛋白原,P = 0.006)和PA:A比(P <0.001)。较高的PA:A比值与较高的Bhalla评分密切相关(r = 0.412,P <0.001)。高比率的COPD和支气管扩张患者表现出更高水平的NT-proBNP(P <0.001)和收缩期肺动脉压(P <0.001)。多项逻辑分析表明,支气管扩张是COPD患者高PA:A比值的独立危险因素(OR = 3.707; 95%CI = 1.888-7.278; P <0.001)。结论:已证明COPD中的支气管扩张与肺动脉相对扩张独立相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号